# The Diet–Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms

**Authors:** Candida Bucciero, Alessandra Croce, Giuliano Castellano, Francesco Beguinot, Pietro Formisano, Giuseppe Portella, Luca Ulianich, Francesca Fiory, Anna Maria Malfitano

PMC · DOI: 10.1007/s12035-026-05748-5 · Molecular Neurobiology · 2026-02-18

## TL;DR

This paper explores how diet can influence multiple sclerosis through oxidative stress and new mechanisms like Nrf2 activation and G-quadruplexes.

## Contribution

The paper introduces emerging dietary mechanisms, such as epigenetic regulation and G-quadruplexes, as potential therapeutic targets for MS.

## Key findings

- Natural compounds in specific diets can enhance Nrf2 activity and benefit MS preclinical models.
- Epigenetic regulation and G-quadruplexes may be novel nutrition-based targets for MS therapy.
- Current evidence for Nrf2 modulation is preclinical, while G-quadruplex targeting remains speculative.

## Abstract

Multiple sclerosis (MS) is an autoimmune neuroinflammatory disease resulting in myelin degeneration and progressive disability. Oxidative stress plays a crucial role in MS pathogenesis and progression. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator of the antioxidant mechanisms and its upregulation is associated with beneficial effects in MS. Among the environmental factors influencing MS onset and progression, diet represents a promising non-pharmacological strategy to modulate Nrf2, potentially improving MS outcomes. Indeed, several natural compounds present in Mediterranean, ketogenic and Paleolithic diets can enhance Nrf2 activity, and exert beneficial effects in preclinical models of MS. In this review, we summarize the key role of oxidative stress in MS and highlight how dietary regimens and Nrf2-modulating natural compounds might have therapeutic potential for MS patients. Additionally, we discuss emerging and still poorly explored mechanisms beyond classical Nrf2 activation, including epigenetic regulation and the stability of DNA/RNA secondary structures known as G-quadruplexes, which are involved in gene expression regulation and may represent novel nutrition-based therapeutic targets. However, while Nrf2 modulation by diet is supported by preclinical and limited clinical evidence, targeting G-quadruplexes as a strategy to counteract oxidative stress in MS remains largely speculative and requires further investigation. Notably, epigenetic mechanisms and G-quadruplexes may represent innovative targets of Nrf2-boosting dietary natural compounds for the development of supplemental therapeutic strategies for MS.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551]
- **Diseases:** multiple sclerosis (MONDO:0005301)

## Full-text entities

- **Genes:** GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}
- **Diseases:** motor impairments (MESH:D000068079), axonal loss (MESH:D012183), hyperactivity (MESH:D006948), spinal cord injury (MESH:D013119), MS (MESH:D009103), progressive disability (MESH:D018450), fatigue (MESH:D005221), EAE (MESH:D004681), autoimmune neuroinflammatory disease (MESH:D000090862), toxicity (MESH:D064420), behavioral deficits (MESH:D019958), cancer (MESH:D009369), weakness (MESH:D018908), neurotoxicity (MESH:D020258), mitochondrial failure (MESH:D051437), AD (MESH:D000544), Mitochondrial damage (MESH:D028361), intracerebral hemorrhage (MESH:D002543), PD (MESH:D010300), nutrient deficiencies (MESH:D007153), dyslipidemia (MESH:D050171), visual dysfunction (MESH:D014786), demyelinating disease (MESH:D003711), OS (MESH:D000079225), inflammation (MESH:D007249), muscle spasticity (MESH:D009128), kidney, liver and neurodegenerative diseases (MESH:D019636)
- **Chemicals:** ROS (MESH:D017382), flavonoid (MESH:D005419), alkaloid (MESH:D000470), isothiocyanates (MESH:D017879), resveratrol (MESH:D000077185), terpenoids (MESH:D013729), myricetin (MESH:C040015), quinolizidine alkaloid (MESH:D000093843), DMF (MESH:D000069462), water (MESH:D014867), ATP (MESH:D000255), polyphenol (MESH:D059808), phytosterol (MESH:D010840), piperine (MESH:C008922), sulforaphane (MESH:C016766), matrine (MESH:D000093842), sugars (MESH:D000073893), isothiocyanate (MESH:C037152), cuprizone (MESH:D003471), Curcumin (MESH:D003474), EGCG (MESH:C045651), H2O2 (MESH:D006861), Compounds (-)
- **Species:** Curcuma longa (turmeric, species) [taxon 136217], Homo sapiens (human, species) [taxon 9606], Morella rubra (Chinese arbutus, species) [taxon 262757], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913339/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913339/full.md

---
Source: https://tomesphere.com/paper/PMC12913339